Ye Shen

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Cell Cycle Arrest

Signaling Pathway

Renal Cell Carcinoma

Top Venues

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Changkun Liu, Zhuo Zou, Shengming Lu, Kun Jin, Ye Shen, Tianbao Huang, Weijian Li, Guangchen Zhou
CircPKN2 promotes ferroptosis in bladder cancer by promoting the ubiquitination of Stearoyl-CoA Desaturase 1. Cancer gene therapy 31 (8) (2024)
Changkun Liu, Zhuo Zou, Shengming Lu, Kun Jin, Ye Shen, Tianbao Huang, Weijian Li, Guangchen Zhou
CircPKN2 promotes ferroptosis in bladder cancer by promoting the ubiquitination of Stearoyl-CoA Desaturase 1. Cancer gene therapy 31 (8) (2024)
Changkun Liu, Zhuo Zou, Shengming Lu, Kun Jin, Ye Shen, Tianbao Huang, Weijian Li, Guangchen Zhou
CircPKN2 promotes ferroptosis in bladder cancer by promoting the ubiquitination of Stearoyl-CoA Desaturase 1. Cancer gene therapy (2024)
Ye Shen, Ruipeng Wu, Zou Zhuo, Ximeng Deng, Weijian Li, Changkun Liu
Identification of circATG9A as a novel biomarker for renal cell carcinoma. Cancer gene therapy (2023)